Osseous metastasis of cutaneous squamous cell carcinoma treated successfully with oxaliplatin, tegafur and leucovorin combination chemotherapy: A case report

International Journal of Clinical and Experimental Medicine

Volumn 5, Issue 1, 2011, Pages 87-91

  Xu, Hong Wei ^a   Ren, Feng ^a   Chen, Wei ^a   Wang, Ying Jie ^a   Chen, Jin ^a   Xie, Zhi Hui ^a   Yang, Jin Hu ^a   Chu, Jian Jun ^a   You, Xu Yang ^a  

^a Soochow University   (China)

Author keywords

Bone metastasis; Chemotherapy; Cutaneous squamous cell carcinoma; PET CT

Indexed keywords

CARMOFUR; FOLINIC ACID; HERBACEOUS AGENT; LENTINAN; OXALIPLATIN; RETINOIC ACID; TEGAFUR; THYMOPENTIN; ZOLEDRONIC ACID;

ADULT; ARTICLE; BLEEDING; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTUSION; CUTANEOUS SQUAMOUS CELL CARCINOMA; DESQUAMATION; ERYTHEMA; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; PAIN; PAPULE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRURITUS; PSORIASIS; PUBIC BONE; SKIN BIOPSY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TIBIA; TUMOR REGRESSION; ULCER;

EID: 84863014844     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344: 975-983.
2. Wells JL, Shirai K. Systemic Therapy for Squamous Cell Carcinoma of the Skin in Organ Transplant Recipients. Am J Clin Oncol 2011.
3. Yang YL, Lai CS, Lin SD, Wang CK, Tsai KB. Intramuscular metastasis of cutaneous squamous cell carcinoma: a case report. Kaohsiung J Med Sci 2003; 19: 188-192.
4. Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, Fojo T. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drugresistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem Pharmacol 1996; 52: 1855-1865.
5. Gilbert J, Murphy B, Dietrich MS, Henry E, Jordan R, Counsell A, Wirth P, Yarbrough WG, Slebos RJ, Chung CH. Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer. Cancer 2011.
6. Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S, Martin C. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2002; 20: 3617-3627.
7. Bennouna J, Perrier H, Paillot B, Priou F, Jacob JH, Hebbar M, Bordenave S, Seitz JF, Cvitkovic F, Dorval E, Malek K, Tonelli D, Douillard JY. A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer. Br J Cancer 2006; 94: 69-73.
8. Sheikh HY, Valle JW, Waddell T, Palmer K, Wilson G, Sjursen A, Craven O, Swindell R, Saunders MP. Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer. Br J Cancer 2008; 99: 577-583.
9. Rudmik L, Lau HY, Matthews TW, Bosch JD, Kloiber R, Molnar CP, Dort JC. Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial. Head Neck 2011; 33: 935-940.
10. Newbold KL, Partridge M, Cook G, Sharma B, Rhys-Evans P, Harrington KJ, Nutting CM. Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. Acta Oncol 2008; 47: 1229-1236.